XIAP induces NF-κB activation via the BIR1/TAB1 interaction and BIR1 dimerization

被引:303
作者
Lu, Miao
Lin, Su-Chang
Huang, Yihua
Kang, Young Jun
Rich, Rebecca
Lo, Yu-Chih
Myszka, David
Han, Jiahuai
Wu, Hao [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA
[2] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[3] Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA
关键词
D O I
10.1016/j.molcel.2007.05.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
In addition to caspase inhibition, X-linked inhibitor of apoptosis (XIAP) induces NF-kappa B and MAP kinase activation during TGF-b and BMP receptor signaling and upon overexpression. Here we show that the BIR1 domain of XIAP, which has no previously ascribed function, directly interacts with TAB1 to induce NF-kappa B activation. TAB1 is an upstream adaptor for the activation of the kinase TAK1, which in turn couples to the NF-kappa B pathway. We report the crystal structures of BIR1, TAB1, and the BiR1/TAB1 complex. The BIR1/TAB1 structure reveals a striking butterfly-shaped dimer and the detailed interaction between BIR1 and TAB1. Structure-based mutagenesis and knockdown of TAB1 show unambiguously that the BIR1/TAB1 interaction is crucial for XIAP-induced TAK1 and NF-kappa B activation. We show that although not interacting with BIR1, Smac, the antagonist for caspase inhibition by XIAP, also inhibits the XIAP/TAB1 interaction. Disruption of BIR1 dimerization abolishes XIAP-mediated NF-kappa B activation, implicating a proximity-induced mechanism for TAK1 activation.
引用
收藏
页码:689 / 702
页数:14
相关论文
共 72 条
[1]
Regulators of apoptosis: Suitable targets for immune therapy of cancer [J].
Andersen, MH ;
Becker, JC ;
Straten, PT .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (05) :399-409
[2]
Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells [J].
Berezovskaya, O ;
Schimmer, AD ;
Glinskii, AB ;
Pinilla, C ;
Hoffman, RM ;
Reed, JC ;
Glinsky, GV .
CANCER RESEARCH, 2005, 65 (06) :2378-2386
[3]
Structural basis for the interaction of TAK1 kinase with its activating protein TAB1 [J].
Brown, K ;
Vial, SCM ;
Dedi, N ;
Long, JM ;
Dunster, NJ ;
Cheetham, GMT .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 354 (05) :1013-1020
[4]
Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[5]
Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(01)00272-0
[6]
Structural and biochemical basis of apoptotic activation by Smac/DIABLO [J].
Chai, JJ ;
Du, CY ;
Wu, JW ;
Kyin, S ;
Wang, XD ;
Shi, YG .
NATURE, 2000, 406 (6798) :855-862
[7]
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis [J].
Chawla-Sarkar, M ;
Bae, SI ;
Reu, FJ ;
Jacobs, BS ;
Lindner, DJ ;
Borden, EC .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (08) :915-923
[8]
Ubiquitin signalling in the NF-κB pathway [J].
Chen, ZJJ .
NATURE CELL BIOLOGY, 2005, 7 (08) :758-U19
[9]
TAK1-binding protein 1 is a pseudophosphatase [J].
Conner, Sarah H. ;
Kular, Gursant ;
Peggie, Mark ;
Shepherd, Sharon ;
Schuttelkopf, Alexander W. ;
Cohen, Philip ;
Van Aalten, Daan M. F. .
BIOCHEMICAL JOURNAL, 2006, 399 (427-434) :427-434
[10]
AN APOPTOSIS-INHIBITING BACULOVIRUS GENE WITH A ZINC FINGER-LIKE MOTIF [J].
CROOK, NE ;
CLEM, RJ ;
MILLER, LK .
JOURNAL OF VIROLOGY, 1993, 67 (04) :2168-2174